Furthermore, high RBP4 levels have been observed in obese subjects, type 2 diabetic patients, adolescents with cardiovascular risk factors, and nonobese individuals low insulin sensitivity suggesting a pathogenic link between RBP4 and IR in humans [20–23]. Here, RBP4 is linked to type 2 diabetes mellitus.